Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Western Sydney Local Health Districit
Scientific Title
Phase I/II clinical trial to assess the safety and biological efficacy of treatment with virus-specific, cytotoxic T-lymphocytes from partially matched third-party unrelated donors, in stem cell transplant patients with viral reactivation unresponsive to standard therapy (Other ID's: U1111-1140-8324 )